commerci
vaccin
ovo
vaccin
yet
develop
infecti
bronchiti
viru
ibv
major
coronaviru
poultri
industri
recombin
ibv
base
beaudett
strain
express
beaudett
spike
protein
beaur
virul
strain
assess
potenti
prototyp
vaccin
applic
embryo
pathogen
assess
observ
effect
hatchabl
andor
product
nasal
discharg
andor
effect
ciliari
activ
trachea
variou
time
point
post
hatch
contrast
commerci
ibv
vaccin
given
ovo
beaur
strain
reduc
hatchabl
caus
nasal
discharg
caus
minim
damag
ciliat
epithelium
trachea
presenc
spike
protein
virul
viru
increas
pathogen
viru
accord
criteria
use
assess
strain
efficaci
show
protect
chick
challeng
virul
ib
viru
dose
depend
manner
egg
passag
strain
increas
pathogen
though
improv
efficaci
base
serolog
protect
virul
challeng
efficaci
protect
bird
virul
challeng
provid
better
serolog
antibodi
respons
induc
serolog
respons
similar
commerci
vaccin
given
dayold
though
commerci
vaccin
provid
slightli
higher
efficaci
result
promis
develop
embryo
safe
efficaci
ibv
vaccin
ovo
applic
infecti
bronchiti
viru
ibv
one
primari
caus
respiratori
diseas
domest
fowl
ibv
primarili
initi
infect
trachea
though
also
infect
kidney
oviduct
epitheli
surfac
infect
ibv
reduc
perform
broiler
lay
bird
drop
egg
product
egg
qualiti
occur
liveattenu
vaccin
infecti
bronchiti
gener
given
chick
day
age
hatcheri
spray
later
field
either
drink
water
spray
howev
liveattenu
vaccin
administ
via
respiratori
tract
must
replic
order
effect
vaccin
earli
age
damag
epitheli
line
trachea
depend
extent
damag
secondari
bacteri
infect
occur
reason
import
assess
post
vaccin
reaction
prepar
vaccin
strain
vaccin
ovo
marek
diseas
infecti
bursal
diseas
commonplac
usa
ovo
deliveri
give
advantag
vaccin
done
prior
hatch
long
vaccin
shown
compat
safe
whilst
consider
work
done
ovo
deliveri
marek
infecti
bursal
diseas
vaccin
littl
work
done
deliv
ibv
vaccin
ovo
due
fact
strain
ibv
embryo
lethal
embryo
use
produc
ib
vaccin
embryo
one
group
shown
ovo
vaccin
ibv
success
accomplish
although
strain
use
residu
pathogen
even
low
titr
uniform
mass
applic
ibv
vaccin
post
hatch
problemat
regard
obtain
even
distribut
spray
ensur
bird
receiv
correct
dosag
drink
water
deliv
ibv
ovo
via
precis
dosag
achiev
could
bring
signific
advantag
poultri
industri
beaudett
strain
highli
eggadapt
viru
massachusett
serotyp
caus
damag
ciliat
epithelium
trachea
vivo
previou
work
demonstr
use
revers
genet
approach
efficaci
beaudett
strain
improv
substitut
beaudett
spike
protein
spike
protein
virul
strain
also
massachusett
serotyp
interestingli
although
alter
cell
tropism
viru
pathogen
alter
strain
abl
afford
signific
protect
vaccin
bird
challeng
virul
strain
aim
work
determin
whether
beaudett
strainbas
ibv
produc
revers
genet
could
use
ovo
vaccin
therefor
safeti
efficaci
strain
investig
specifi
pathogen
free
spf
white
leghorn
chicken
embryon
egg
lohmann
germani
use
chick
hatch
contain
environ
transfer
neg
pressur
isol
remaind
experi
chick
starter
crumb
water
provid
ad
libitum
cours
experi
beaur
strain
prepar
use
revers
genet
describ
previous
virus
grown
primari
chick
kidney
cell
passag
ten
time
embryon
egg
give
two
commerci
vaccin
nobili
intervet
refer
text
ib
mm
fort
dodg
refer
text
massachusett
serotyp
use
strain
adapt
chick
kidney
cell
also
use
titr
virus
establish
embryon
egg
calcul
use
method
reed
muench
express
egg
infecti
dose
eid
virus
dilut
marek
diseas
vaccin
diluent
nobili
marek
diluent
intervet
ibv
challeng
nonck
adapt
massachusett
serotyp
strain
given
oculonas
rout
mlbird
dose
eid
per
bird
embryo
vaccin
egg
day
embryo
develop
inocul
amniot
fluid
use
gaug
cm
long
needl
viru
dilut
ml
inocul
placebo
receiv
ml
diluent
egg
hatch
separ
incub
hatch
assess
day
incub
dayold
vaccin
bird
receiv
ml
vaccin
dilut
via
oculonas
rout
examin
gener
health
done
daili
cours
experi
nasal
discharg
assess
gentli
squeez
nare
chick
determin
fluid
visibl
assess
ciliostasi
done
previous
describ
chick
kill
intraven
inject
barbitur
trachea
remov
asept
ten
mm
explant
trachea
observ
microscop
ciliari
activ
ring
score
accord
percentag
cilia
beat
lumin
surfac
post
challeng
ciliostasi
assess
done
day
day
coincid
peak
replic
ibv
trachea
serolog
respons
ibv
studi
use
elisa
briefli
elisa
plate
coat
antigen
incub
serial
dilut
test
chicken
serum
h
wash
rabbit
anti
chicken
antiserum
conjug
alkalin
phosphatas
ad
min
wash
pnitrophenyl
phosphat
substrat
ad
min
titr
calcul
comparison
known
neg
posit
control
posit
respons
consid
log
twotail
ttest
use
compar
ciliari
activ
serolog
respons
pvalu
less
consid
signific
thirtythre
spf
egg
inocul
high
dose
beaur
eid
eid
vaccin
three
grade
dose
commerci
vaccin
eid
placebo
vaccin
group
includ
chick
allow
hatch
separ
hatcher
live
chick
count
day
incub
group
least
chick
form
hatch
rate
allow
day
post
hatch
bird
group
examin
nasal
discharg
five
chick
group
euthan
trachea
remov
assess
ciliari
activ
remain
chick
bled
serum
collect
week
challeng
virul
ibv
day
post
challeng
remain
bird
group
euthan
trachea
remov
assess
ciliari
activ
one
hundr
spf
egg
inocul
dose
eid
beaur
vaccin
candid
placebo
chick
allow
hatch
separ
hatcher
live
chick
count
day
incub
day
post
hatch
five
chick
group
euthan
trachea
remov
assess
ciliari
activ
group
onedayold
bird
vaccin
eid
commerci
vaccin
via
oculonas
rout
day
post
vaccin
five
chick
group
euthan
trachea
remov
assess
ciliari
activ
chick
bled
serum
collect
week
challeng
virul
ibv
week
day
post
challeng
bird
group
euthan
trachea
remov
assess
ciliari
activ
sixti
spf
egg
inocul
dose
eid
vaccin
candid
chick
allow
hatch
separ
hatcher
live
chick
count
day
incub
day
post
hatch
chick
examin
nasal
discharg
chick
bled
serum
collect
week
challeng
virul
ibv
day
post
challeng
bird
group
euthan
trachea
remov
assess
ciliari
activ
fifti
spf
egg
inocul
eid
beaur
eid
two
differ
dose
vaccin
eid
placebo
egg
mark
mix
singl
incub
hatch
assess
count
mark
egg
remain
fifti
spf
egg
inocul
viru
eid
placebo
egg
mark
mix
singl
incub
hatch
assess
count
mark
egg
remain
determin
candid
vaccin
base
beaudett
strain
safe
embryo
vaccin
five
experi
perform
embryon
egg
inocul
day
incub
experi
separ
hatcher
use
therefor
perform
hatcher
may
influenc
result
experi
egg
hatch
machin
avoid
influenc
individu
hatcher
experi
commerci
vaccin
includ
determin
effect
hatchabl
experi
spf
egg
inocul
high
dose
beaur
grade
dose
commerci
vaccin
shown
fig
beaur
gave
slightli
lower
hatch
placebo
vaccin
lowest
hatch
candid
vaccin
beaur
group
four
fewer
chick
hatch
placebo
group
reduct
hatch
may
due
pathogen
beaur
could
also
effect
hatch
differ
group
separ
hatcher
contrast
candid
vaccin
commerci
vaccin
gave
poor
hatch
three
group
even
though
hatch
hatch
hatch
fold
lower
dose
beaur
inocul
experi
spf
egg
inocul
less
beaur
eid
experi
addit
strain
includ
determin
egg
passag
could
improv
immunogen
strain
without
affect
pathogen
inocul
candid
vaccin
caus
lower
hatch
placebo
hatch
experi
hatch
vaccin
candid
give
best
result
fig
though
slightli
lower
placebo
vaccin
differ
hatch
vaccin
candid
may
due
differ
hatcher
use
third
experi
spf
egg
inocul
eid
inocul
gave
higher
hatch
hatch
placebo
whilst
inocul
caus
slightli
lower
hatch
placebo
fig
fourth
experi
spf
egg
inocul
beaur
eid
second
commerci
vaccin
includ
dose
eid
eid
exclud
variabl
hatcher
egg
experi
place
hatch
unit
gave
higher
hatch
fig
hatch
placebo
experi
whilst
beaur
vaccin
gave
slightli
lower
hatch
placebo
vaccin
gave
low
hatchabl
dose
eid
eid
fifth
experi
spf
egg
inocul
viru
eid
donor
spike
gene
insert
placebo
exclud
variabl
hatcher
egg
experi
place
hatch
unit
gave
hatch
comparison
hatch
control
group
bird
held
isol
trial
difficult
examin
clinic
paramet
associ
ibv
tracheal
rale
cough
sneez
experi
ovo
inocul
beaur
caus
morbid
post
hatch
observ
period
nasal
discharg
detect
bird
vaccin
ovo
either
beaur
fig
suggest
virus
pathogen
contrast
hatch
ovo
vaccin
nasal
discharg
examin
occurr
nasal
discharg
dose
depend
third
experi
none
bird
vaccin
nasal
discharg
test
day
post
hatch
data
shown
overal
result
suggest
beaur
vaccin
candid
safe
embryo
vaccin
presenc
spike
gene
virul
effect
hatchabl
caus
clinic
sign
post
hatch
analysi
ciliari
activ
post
vaccin
use
measur
safeti
ibv
vaccin
experi
three
bird
group
five
beaur
ovovaccin
group
euthan
day
post
hatch
ciliari
activ
assess
result
shown
fig
inocul
ovo
although
assess
three
bird
gave
high
ciliostasi
score
independ
dose
given
ciliostasi
score
beaur
vaccin
significantli
differ
though
significantli
higher
placebo
vaccin
p
beaur
p
score
accept
ground
safeti
suggest
neither
virus
pathogen
inclus
spike
gene
increas
pathogen
experi
extens
analysi
ciliostasi
caus
candid
vaccin
undertaken
fig
experi
eggpassag
vaccin
candid
includ
beaur
vaccin
caus
highest
level
ciliostasi
beaudett
base
strain
though
signific
differ
ciliostasi
caus
beaudett
vaccin
candid
time
point
data
shown
peak
ciliostasi
beaudett
base
strain
detect
day
post
hatch
ciliostasi
level
decreas
time
ciliostasi
caus
commerci
vaccin
given
dayold
assess
day
post
vaccin
highest
ciliostasi
detect
day
though
significantli
differ
candid
vaccin
given
ovo
p
experi
serolog
respons
compar
week
post
hatch
fig
vaccin
given
ovo
dose
gave
highest
antibodi
respons
bird
seroconvert
regardless
dose
lowest
dose
vaccin
gave
significantli
higher
respons
p
beaur
p
beaur
gave
lower
antibodi
respons
signific
p
sixti
percent
beaur
vaccin
vaccin
seroconvert
week
post
hatch
experi
vaccin
ovo
gave
highest
antibodi
respons
beaudett
base
strain
bird
group
seroconvert
fig
respons
significantli
higher
vaccin
p
beaur
p
gave
approxim
equal
respons
bird
seroconvert
group
data
shown
vaccin
given
dayold
gave
highest
antibodi
respons
experi
bird
respond
howev
respons
significantli
differ
induc
p
experi
vaccin
ovo
gave
highest
antibodi
respons
bird
group
seroconvert
fig
respons
significantli
higher
vaccin
ovo
p
bird
vaccin
seroconvert
data
shown
experi
vaccin
dose
beaudettebas
virus
eid
bird
challeng
week
post
hatch
virul
viru
ciliari
activ
test
day
post
challeng
fig
purpos
bird
vaccin
differ
dose
vaccin
pool
give
group
bird
base
ciliari
activ
less
indic
protect
vaccin
bird
protect
ovovaccin
bird
protect
beaur
ovovaccin
bird
protect
nonvaccin
bird
least
ciliostasi
result
indic
express
spike
protein
virul
increas
protect
capac
vaccin
comparison
beaur
experi
vaccin
dose
beaudettebas
virus
eid
bird
challeng
week
post
hatch
virul
viru
ciliari
activ
test
day
post
challeng
fig
nonvaccin
bird
least
ciliostasi
inocul
ovo
protect
bird
whilst
none
beaur
ovo
vaccin
protect
bird
vaccin
ovo
protect
vaccin
administ
dayold
provid
protect
comparison
experi
result
suggest
efficaci
may
dose
andor
time
depend
beaur
vaccin
better
protect
given
high
dose
eid
challeng
fig
lower
dose
challeng
experi
bird
challeng
week
post
hatch
virul
viru
ciliari
activ
test
day
post
challeng
fig
nonvaccin
bird
least
ciliostasi
one
bird
ovovaccin
group
euthan
due
genet
defect
inocul
ovo
protect
vaccin
whilst
ovovaccin
bird
protect
overal
result
indic
ibv
beaudett
strain
express
spike
gene
strain
safe
deliveri
embryo
potenti
efficaci
vaccin
poultri
industri
move
toward
greater
use
ovo
vaccin
purpos
studi
determin
ibv
vaccin
base
beaudett
strain
could
deliv
via
rout
surprisingli
even
high
dose
beaudett
base
strain
test
significantli
affect
abil
chick
hatch
fig
caus
clinic
sign
post
hatch
fig
experi
data
shown
compar
vaccin
placebo
contrast
work
wakenel
sharma
whose
ibv
ovo
vaccin
candid
show
residu
pathogen
dose
pfu
expect
embryo
adapt
commerci
vaccin
greatli
reduc
hatchabl
fig
gave
clinic
sign
post
hatch
fig
reason
recombin
beaudett
strain
safe
ovo
vaccin
unknown
though
could
associ
passag
histori
particular
strain
parent
beaudett
viru
passag
embryo
commerci
vaccin
also
passag
ck
cell
precis
passag
histori
unknown
subsequ
recombin
virus
passag
ck
cell
line
result
hodgson
et
al
hatch
chick
found
substitut
beaudett
spike
protein
virul
strain
increas
pathogen
strain
beaur
embryo
post
hatch
result
suggest
abil
viru
reduc
hatchabl
comparison
placebo
experi
associ
spike
protein
may
associ
differ
gene
interest
note
egg
passag
strain
increas
pathogen
base
hatch
criteria
ciliostasi
test
use
determin
damag
trachea
follow
growth
ibv
tissu
beaudettebas
vaccin
strain
caus
tracheal
ciliostasi
follow
ovo
inocul
accept
level
respect
vaccin
safeti
indic
beaudett
strain
abl
replic
trachea
ovovaccin
chick
contrast
virtual
tracheal
ciliostasi
caus
beaudett
strain
follow
inocul
chick
oculonas
rout
although
beaudett
caus
ciliostasi
inocul
onto
tracheal
organ
cultur
suggest
deliveri
ibv
ovo
enabl
grow
better
trachea
post
hatch
deliveri
possibl
due
embryo
ingest
amniot
fluid
contain
viral
inoculum
introduc
viru
directli
trachea
contrast
commerci
vaccin
test
caus
high
ciliostasi
score
post
hatch
deliveri
ovo
fig
contrast
result
commerci
vaccin
deliv
dayold
nose
eyedrop
applic
fig
suggest
deliveri
ibv
ovo
enabl
grow
better
trachea
deliveri
dayold
interestingli
spike
protein
appear
affect
amount
ciliostasi
caus
beaur
strain
strain
show
similar
result
two
experi
fig
eid
eid
contrast
singl
experi
fig
eid
eggpassag
viru
gave
higher
significantli
higher
ciliostasi
score
difficult
draw
conclus
singl
experi
result
suggest
egg
passag
may
increas
abil
viru
grow
trachea
although
serolog
respons
ibv
correl
protect
virul
ibv
respiratori
challeng
use
criterion
assess
immunogen
viru
strain
host
signific
differ
seen
serolog
respons
induc
beaur
two
experi
fig
b
interest
note
dose
depend
regard
serolog
respons
rate
seroconvers
viru
give
similar
respons
seroconvers
rate
fig
versu
b
howev
eggpassag
induc
significantli
higher
respons
fig
c
respons
significantli
differ
induc
commerci
vaccin
given
dayold
fig
indic
high
level
immunogen
viru
reason
differ
immunogen
eggpassag
viru
requir
investig
though
one
could
specul
viru
may
replic
trachea
subsequ
induc
better
immun
respons
efficaci
beaudettederiv
virus
potenti
vaccin
studi
use
respiratori
challeng
virul
ibv
strain
use
tracheal
ciliari
activ
criterion
protect
high
dose
eid
induc
level
protect
compar
induc
commerci
vaccin
given
ovo
fig
though
commerci
vaccin
safe
determin
criteria
describ
level
protect
result
ovo
vaccin
higher
induc
beaur
suggest
posit
effect
spike
protein
virus
appear
grow
equal
well
trachea
fig
c
specul
increas
protect
observ
due
spike
protein
homolog
spike
protein
challeng
viru
altern
cytotox
cell
respons
thought
import
protect
ib
challeng
possibl
amino
acid
differ
beaur
spike
protein
contain
relev
ctl
epitop
protect
challeng
result
present
herein
agreement
find
vaccin
given
gave
higher
protect
virul
challeng
vaccin
beaur
observ
dose
andor
time
depend
protect
afford
lower
dose
challeng
week
protect
fell
fig
fig
contrast
eggpassag
viru
lower
dose
eid
fig
c
provid
protect
two
experi
suggest
vaccin
adapt
growth
embryo
immunogen
summari
vaccin
candid
base
beaudett
strain
safe
deliveri
ovo
vaccin
embryo
determin
effect
hatchabl
nasal
discharg
post
hatch
ciliari
activ
express
spike
protein
alter
pathogen
ribv
basi
criteria
express
spike
protein
rather
beaudett
spike
protein
egg
passag
viru
express
spike
protein
improv
efficaci
viru
confirm
potenti
use
candid
vaccin
field
futur
work
concentr
effect
matern
deriv
antibodi
efficaci
virus
vaccin
candid
follow
ovo
vaccin
